Prevalence of Hepatitis B and C Viruse’s Infections among Hemodialysis Patients in Tehran, Iran

Morteza Alibakhshikenari*

Received: November 06, 2018;   Published: November 19, 2018

DOI: 10.26717/BJSTR.2018.11.002065

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

A cross-sectional study was done from (April- May 2016) at five health facilities among hemodialyzed patients. Patients undergoing hemodialysis (HD) potentially have an increased risk of infection due to impairment of the immune response and to the multiple transfusion requirements. Using questionnaire brief history was taken from each volunteer patient. By collecting blood, serum was separated and screened for the presence of HBsAg and anti-HCV antibody using ELISA test method. In this study a total of 253 patients were recruited of whom 74.3% were men, the prevalence of HBsAg and HCV antibody were 1.2 and 2.8% respectively, 4% of patients had markers of at least one viral infection marker; with only one patient (0.4%) was being co-infected.

Keywords : Hemodialysis, Serum, Hbsag, Anti-HCV, ELISA Test Method, Hepatitis Viruses, Erythropoietin Therapy, HBV Vaccination, Chronic HD Patients, Automated Immunoassay Analyzer